Stromal proteome expression profile and muscle-invasive bladder cancer research

Cancer Cell International

Volumn 12, Issue , 2012, Pages

  Niu, Haitao ^a   Jiang, Haiping ^a   Cheng, Bo ^b   Li, Xinhui ^a   Dong, Qian ^a   Shao, Leping ^a   Liu, Shiguo ^a   Wang, Xinsheng ^a  

^a QINGDAO UNIVERSITY   (China)

^b Department of Urology   (China)

Author keywords

Biomarker panel; Muscle invasive bladder transitional cell carcinoma; Proteome; Stroma; Subcellular pattern

Indexed keywords

PROTEOME;

ARTICLE; BIOINFORMATICS; BLADDER CANCER; CANCER RESEARCH; CHROMATOGRAPHY; CONTROLLED STUDY; FOCAL ADHESION; HUMAN; HUMAN CELL; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RIBOSOME; STROMA CELL; TANDEM MASS SPECTROMETRY;

EID: 84865299217     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-12-39     Document Type: Article

References (19)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
2. Niu HT, Xu T, Zhang YB, Pang DQ, Zhang ZL, Wu S, Cheng B, Wang Y, Chang JW, Sun G. Outcomes for a large series of radical cystectomies for bladder cancer. Eur J Surg Oncol 2008, 34:911-915. 10.1016/j.ejso.2008.01.010, 18294806.
3. Li X, Ma Q, Xu Q, Duan W, Lei J, Wu E. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment. Curr Pharm Des 2012, 17:2404-2415.
4. Li D, Li JQ, Yang SG. An integrated strategy for functional analysis in large-scale proteomic research by gene ontology. Prog Biochem Biophys 2005, 32:1026-1029.
5. Tong W, Harris S, Cao X, Fang H, Shi L, Sun H, Fuscoe J, Harris A, Hong H, Xie Q, Perkins R, Casciano D. Development of public toxicogenomics software for microarray data management and analysis. Mutat Res 2004, 549:241-253. 10.1016/j.mrfmmm.2003.12.024, 15120974.
6. Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. J Biol Chem 2010, 285:5461-5471. 10.1074/jbc.M109.037127, 2820774, 19940135.
7. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, Man K, Ng IO. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 2011, 140:322-331. 10.1053/j.gastro.2010.10.006, 20951699.
8. Nagaharu K, Zhang X, Yoshida T, Katoh D, Hanamura N, Kozuka Y, Ogawa T, Shiraishi T, Imanaka-Yoshida K. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol 2011, 178:754-763. 10.1016/j.ajpath.2010.10.015, 3069868, 21281808.
9. Kashani-Sabet M, Rangel J, Torabian S, Nosrati M, Simko J, Jablons DM, Moore DH, Haqq C, Miller JR, Sagebiel RW. Tenascin-X is a novel diagnostic marker of malignant mesothelioma. Am J Surg Pathol 2009, 33:1673-1682. 10.1097/PAS.0b013e3181b6bde3, 2783994, 19738457.
10. Kashani-Sabet M, Rangel J, Torabian S, Nosrati M, Simko J, Jablons DM, Moore DH, Haqq C, Miller JR, Sagebiel RW. A multi-marker assay to distinguish malignant melanomas from benign nevi. Proc Natl Acad Sci U S A 2009, 106:6268-6272. 10.1073/pnas.0901185106, 2662963, 19332774.
11. Murphy RF. Communicating subcellular distributions. Cytometry A 2010, 77:686-692. 2901539, 20552685.
12. Lane N, Martin W. The energetics of genome complexity. Nature 2010, 467:929-934. 10.1038/nature09486, 20962839.
13. Brakmann S. Single-molecule analysis. A ribosome in action. Nature 2010, 464:987-988. 10.1038/464987a, 20393548.
14. Kühnle J, Shillcock J, Mouritsen OG, Weiss M. A modeling approach to the self-assembly of the Golgi apparatus. Biophys J 2010, 98:2839-2847. 10.1016/j.bpj.2010.03.035, 2884245, 20550896.
15. Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang J, Perry SR, Labrot ES, Wu X, Lis R, Hoshida Y, Hiller D, Hu B, Jiang S, Zheng H, Stegh AH, Scott KL, Signoretti S, Bardeesy N, Wang YA, Hill DE, Golub TR, Stampfer MJ, Wong WH, Loda M, Mucci L, Chin L, DePinho RA. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 2011, 470:269-273. 10.1038/nature09677, 21289624.
16. Parsons JT, Slack-Davis J, Tilghman R, Roberts WG. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res 2008, 14:627-632. 10.1158/1078-0432.CCR-07-2220, 18245520.
17. Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F, Lisanti MP. Stromal-epithelial metabolic coupling in cancer: Integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol 2011, 43:1045-1051. 10.1016/j.biocel.2011.01.023, 3102770, 21300172.
18. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come?. CA Cancer J Clin 2010, 60:244-272. 10.3322/caac.20077, 20566675.
19. Flavin R, Zadra G, Loda M. Metabolic alterations and targeted therapies in prostate cancer. J Pathol 2011, 223:283-294. 3197856, 21125681.